DHTL

Docmode Health Technologies Limited

Listed company · ISIN INE0OGG01015 · NSE SM · FV ₹10
Last price
₹24
-4.81%today
What this company does

Docmode Health Technologies Limited is a listed company. It booked ₹8 cr of revenue in its latest half year (H2 FY26) and kept -0.9% of sales as profit.

29out of 100
Equitytale Health Score
Fragile

Healthier than 29% of listed companies we score, on the 4 of 6 measures we could read for it. Each measure is ranked against the 416–2,886 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
oversold
RSI (14)
27

At close. Not part of the score.

Profitability & returns10

How much profit it earns on the money it employs

Balance sheet17

How much it owes, and whether earnings cover the interest

Valuation67

What today's price implies, against our models or its peers

Governance & risk41

How much of the promoters' stake is pledged, and how much they hold

Not measurable for this company: cash quality, growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Some things to watch
Strengths
—
Watch-outs
! Currently loss-making
! Thin -0.9% net margin
! Sales down 64% vs last year
! 37.4% of promoter stake pledged
! Low -2.6% return on equity

What if I invest in DHTL?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 5% a year, it would become
₹15.50 lakh

The slider starts at 5%, taken from a generic assumption, not this company's history. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest half year + price
₹24▼ -4.81%
latest close · 2026-10-01
52-wk low ₹2430 sessions so far52-wk high ₹39
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/B ratio1.48Moderate
Below bookModerateHigh
EV / EBITDA115.7High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity-2.6%Loss
WeakFairStrong ▸15%
Return on capital1.0%Weak
WeakFairStrong
Net margin-0.9%Loss
ThinDecentStrong
EBITDA margin0.6%Thin
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.73Moderate
LowModerateHigh ▸1
Interest cover0.4×Risky
RiskyOkayStrong ▸5×
Current ratio0.73Tight
Tight ◂1HealthyAmple
More figures
Market cap
₹8 cr
Book value
₹16
EPS
₹-0.21
latest half year
Net debt
₹4 cr
owes more than its cash
Enterprise value
₹11 cr
EBITDA
₹9.6 L
annualised
EBIT
₹9.6 L
annualised
Operating margin
0.6%
Return on assets
-0.4%
Earnings yield
—
P/S
0.49
Sales / share
₹48.5
Tax rate
—
Face value
₹10
Shares
0.3 cr
Working capital
₹-6 cr
Current assets
₹17 cr
Current liabilities
₹24 cr
Delivery %
87.3%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest half year; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-10-01.

Worth vs price · from the exchange filings
not investment advice
Hard to value confidentlyLow confidence
The company's latest annual profit was negative, so we won't call it cheap off older profits.
Models span ₹171–₹171, midpoint ₹171

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · H2 FY26 (consolidated)
Revenue from Operations₹8 cr
Other Income₹1 cr
Total Income₹9 cr
Cost of Materials₹0 cr
Purchases of Stock-in-Trade₹4 cr
Inventory Change (±)₹2 cr
Employee Benefit Expense₹1 cr
Finance Costs₹11.4 L
Other Expenses₹2 cr
Total Expenses₹9 cr
Profit before Tax₹-6.6 L
Tax Expense₹0 cr
Net Profit₹-6.6 L
Net margin on total income-0.7%
Where the money goes · H2 FY26
% of total spend
Materials + stock-in-trade₹6 cr67.2%
Employee benefit expense₹1 cr12.1%
Finance costs₹11.4 L1.3%
Other expenses₹2 cr19.4%
Total income ₹9 cr

The company made a net loss of ₹6.6 L this half year — income covered only ₹99 of every ₹100 it spent on costs and tax.

Half-yearly results · consolidated (₹ cr)
MetricH2 FY25H1 FY26H2 FY26
Revenue21 cr18 cr8 cr
Total income21 cr18 cr9 cr
Expenses23 cr18 cr9 cr
Profit before tax-1 cr-9.2 L-6.6 L
Tax-7.5 L0 cr0 cr
Net profit (owners' share)-1 cr-9.2 L-6.6 L
Net margin (owners' share, on revenue)-6.4%-0.5%-0.9%
EPS (₹)-4.79-0.29-0.21
YoY (latest quarter): total income -58.1% · net profit —
Balance sheet & cash flow · as of Mar 2026
Moderate debt
Total assets
₹33 cr
Shareholder equity
₹5 cr
parent shareholders
Total debt
₹4 cr
Cash
₹17.8 L
Who owns it · 2026-03-31
⚑ 37.4% pledged
Promoter
29.5%
Public
70.5%
Promoter stake down 17.9% over the last 4 quarters.
Smart-money activity
Bulk / block deals
SoldRAMESH KUMAR JAIN · NSE44,000 @ ₹24.951 Oct 26
BoughtRAMESH JAIN HUF · NSE40,000 @ ₹24.951 Oct 26
SoldRAMESH KUMAR JAIN · NSE64,800 @ ₹25.8830 Sep 26
Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 21 named members
owning 29.5% between them · as of 2026-03-31
PAULSON PAUL THAZHATHEDATH16.37%
HANS ALBERT LEWIS13.07%
KENNETH PAUL LEWIS0.06%
Anjana Ravindra Bhattno shares
Atlas Learning Private Limitedno shares
Caroline Luxano shares
CCME World Services Private Limitedno shares
Docmode Endeavors LLPno shares

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

Money it raised, and what it did with it

When a company raises money from investors, it has to say up front what the money is for. The rules then make it report, every three months until the money is gone, how much of each of those things it has actually paid for — so a promise made while asking for the money can be checked afterwards.

₹7 cr raised in Feb 2024 by selling shares to the public

As of Mar 2025, the company says it has spent 100% of what it set aside.

Purchase of IT infrastructure and operating system
100%
₹3 cr of ₹3 cr
Meeting incremental working capital requirements
100%
₹2 cr of ₹2 cr
General corporate purposes
100%
₹1 cr of ₹1 cr

Every figure above is taken from the statement the company files with the stock exchange each quarter, for as long as money it has raised remains unspent. The only thing we work out is how much of each stated purpose has been paid for — one number divided by another from the same filing. Whether a plan that changed was a good change is not something a filing can tell you. See the filing

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.